One-time trial production of Workshop 201 of Gaolan Port Base of Zhuhai Federal Pharmaceutical Company was successful (sulbactam sodium) 2025-05-29
The latest news: NHU cystine production line will be stopped for maintenance in June 2025. 2025-05-29
Latest news: NHU has officially entered the leucine market and is expected to ship in the third quarter. 2025-05-29
The latest news: NHU cystine production line will be stopped for maintenance in June 2025. 2025-05-29
Tianxin Pharmaceutical Co., Ltd.: Compared with the same period of last year 2025-05-16
The latest news: Xinfu Technology Calcium Pantothenate (calcium pantothenate B5)5 lowered its external quotation from May 16th. 2025-05-16
Jindawei coenzyme Q10 technical transformation and expansion project has been completed, and it is currently producing at full capacity. 2025-05-14
Jin Dawei: Vitamin A and Vitamin D3 are currently produced at full capacity. 2025-05-14
Guangji Pharmaceutical's operating income in 2024 was 638 million yuan, with a net profit loss, and the market price of vitamin B2 was in a downturn. 2025-04-30
Shandong NHU will overhaul the vitamin E production line in early June. 2025-04-15
Novartis plans to expand its US-based manufacturing and R&D footprint with a total investment of $23B over the next 5 years 2025-04-15
DSM-Fenmeiyi's factory for producing vitamin A and vitamin E precursors will be discontinued. 2025-04-09
Garden creatures: what is the capacity of vitamin D3 feed after expansion? 2025-04-09
Garden creatures: biotin and vitamin B6 specify the production time 2025-04-09
NHU: The main vitamin series products are in the US tariff exemption list. 2025-04-09
Major vitamin products are included in the US tariff exemption list. 2025-04-09
Three major domestic manufacturers of nicotinamide stopped reporting. 2025-04-03
Folic acid has mainstream manufacturers to resume quotation. 2025-03-31
Jiangxi Tianxin Pharmaceutical will stop reporting and signing vitamin E products from now on. 2025-03-25
Wanhua Chemical Vitamin A has been put into production recently. 2025-03-18
Shanghai FIC: No quotation was made at the vitamin C exhibition, but the factory withdrew the previous quotation. 2025-03-18
Grain Rain Bio-Health Co-production Project was completed, mainly including maltodextrin, psicose, glucose and sorbitol. 2025-03-14
Inner Mongolia Yiyuan Bio invested 110 million yuan to build a new production project of chondroitin and collagen peptide. 2025-03-14
FDA plans to cancel the Self-GRAS certification, and synthetic biological products have great influence. 2025-03-14
BASF announced the resumption of vitamin A production in early April 2025 as originally planned. 2025-03-14
BASF announced the resumption of vitamin E production ahead of schedule. 2025-03-14
BASF announced the rumor of vitamin E, and the restart is scheduled for mid-May 2025. 2025-03-13
It is estimated that BASF will resume production of vitamin A and vitamin E ahead of schedule. 2025-03-12
The trehalose high-end pharmaceutical project of Shandong Tianli Pharmaceutical Co., Ltd. is accelerating and will be put into production in May 2025. 2025-03-05
Some workshops of Ningxia Tianxin Pharmaceutical will enter trial production in May 2025. 2025-03-05
Henan Muyuan Anliang Synthetic Biotechnology Co., Ltd. has put into production with an annual output of 30,000 tons of synthetic organisms as fermented amino acids. 2025-03-05
Hebei Huarong Pharmaceutical resumed the quotation of vitamin B12. 2025-03-05
共
4619 个 页次:
1 /
145 页
32 个/页
首页 上一页 下一页 尾页
转到:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
Our Advantages of Reports
①All reports written by ourselves ②All data having original sources ③Information is the latest ④Continuous historical data ⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract) ②Transfer payment to company's bank account ③After accepting payment we email the report to clients (PDF format) ④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd ②Beneficiary's Account No.:110060239018002127366 ③Name of bank:Bank of Communications Beijing Branch,Fuwai Sub-Branch ④Address of bank:NO7,FUWAISTREET,XICHENG DISTRICT,BEIJING,CHINA SWIFT CODE:COMMCNSHBJG